Inventor · disambiguated record
Ling Tong
Also filed as: TONG LING
40 granted patents·13 pending applications·299 citations·filing 2002–2024
97Inventor score
Files withSCHERING CORP16MERCK SHARP & DOHME12MERCK SHARP & DOHME LLC11ACTON III JOHN J1ARASAPPAN ASHOK1
Top patents by PatentIndex Score
53 records- 0195US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0292US8178553B2Compounds for the treatment of inflammatory disordersLAVEY BRIAN J·Filed 2010·Granted May 15, 2012·46 cites·19 claims
- 0392US7524842B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Apr 28, 2009·19 cites·34 claims
- 0492US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0591US8569336B2Compounds for the treatment of inflammatory disordersTONG LING·Filed 2009·Granted Oct 29, 2013·44 cites·4 claims
- 0691US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0788US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 0886US7772263B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Granted Aug 10, 2010·7 cites·31 claims
- 0986US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1084US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 1184US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1284US7217732B2Cannabinoid receptor agonistsSCHERING CORP·Filed 2003·Granted May 15, 2007·20 cites·28 claims
- 1383US11427616B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2019·Granted Aug 30, 2022·3 cites·48 claims
- 1483US9555038B2Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·6 cites·24 claims
- 1582US7718702B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2005·Granted May 18, 2010·5 cites·34 claims
- 1682US7071213B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Jul 4, 2006·16 cites·20 claims
- 1782US7067539B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Jun 27, 2006·18 cites·31 claims
- 1879US2025206781A1Pcsk9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1978US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 2078US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 2176US7507767B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2002·Granted Mar 24, 2009·8 cites·37 claims
- 2274US10981902B25-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted Apr 20, 2021·1 cites·18 claims
- 2374US7683088B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Mar 23, 2010·1 cites·19 claims
- 2473US12209145B2PCSK9 antagonist compoundsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 28, 2025·0 cites·29 claims
- 2573US9828365B2Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Nov 28, 2017·2 cites·21 claims
- 2672US8541572B2Compounds for the treatment of inflammatory disordersKOZLOWSKI JOSEPH A·Filed 2009·Granted Sep 24, 2013·2 cites·4 claims
- 2771US10836775B26,6-fused heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2017·Granted Nov 17, 2020·1 cites·13 claims
- 2865US7253189B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2003·Granted Aug 7, 2007·2 cites·53 claims
- 2965US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3064US9433621B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2011·Granted Sep 6, 2016·1 cites·7 claims
- 3163US2025171467A1Fused pyrazole amide analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3262US2025188057A1Non-aromatic cyclic-pyrimidine analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3361US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3460US2025026762A1Fused pyrazole urea analogs as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3556US2024083910A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesBERGER RICHARD·Filed 2021·Application pending·0 cites
- 3656US2024059693A1Fused bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesvirusesMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 3754US2024067657A1Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesvirusesARMACOST KIRA A·Filed 2021·Application pending·0 cites
- 3852US12497405B2Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes virusesMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 16, 2025·0 cites·18 claims
- 3952US7645774B2Cannabinoid receptor ligandsSCHERING CORP·Filed 2005·Granted Jan 12, 2010·0 cites·30 claims
- 4052US2023391758A1Modified benzofuran-carboxamides as glucosylceramide synthase inhibitorsMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 4151US2024026024A1Cd73 antigen-binding protein and application thereofSHANGHAI HUAOTA BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4249US11970479B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 30, 2024·0 cites·18 claims
- 4349US2016257697A1Thiophene-substituted tetracyclic compounds and methods ofuse thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 4446US10738062B2Chromane-substituted tetracyclic compounds and uses thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2017·Granted Aug 11, 2020·0 cites·14 claims
- 4545US8450355B2Compounds for the treatment of inflammatory diseasesWONG MICHAEL K C·Filed 2009·Granted May 28, 2013·0 cites·19 claims
- 4644US11339156B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2018·Granted May 24, 2022·0 cites·11 claims
- 4743US8859529B2Compounds for the treatment of inflammatory disordersSHANKAR BANDARPALLE B·Filed 2009·Granted Oct 14, 2014·0 cites·16 claims
- 4842USD824343SLED chipENRAYTEK OPTOELECTRONICS CO·Filed 2016·Granted Jul 31, 2018·3 cites·1 claims
- 4941US10646494B2Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2017·Granted May 12, 2020·0 cites·16 claims
- 5041US9233979B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 12, 2016·0 cites·16 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ling Tong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →